A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients with Mild to Moderate Pneumonia due to COVID-19
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Golden Biotechnologies Corporation
Start Date
February 23, 2021
End Date
February 28, 2023
Administered By
Institutes and Centers
Awarded By
Golden Biotechnologies Corporation
Start Date
February 23, 2021
End Date
February 28, 2023